Aptevo Therapeutics

APVO

Börsenwert 1,4 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Stonepine Capital Management Bend, Oregon	3,48 Mio. $	–	–	–
2	2 Point72 Asset Management Stamford, Connecticut	2,08 Mio. $	–	–	–
3	3 Renaissance Technologies New York	1,46 Mio. $	–	–	–
4	4 Vanguard Group Malvern, Pennsylvania	994.000 $	–	–	–
5	5 Sessa Capital New York	906.000 $	–	–	–
6	6 Park West Asset Management San Francisco, California	887.000 $	–	–	–
7	7 Dimensional Fund Advisors Austin, Texas	827.000 $	–	–	–
8	8 Acadian Asset Management Boston, Massachusetts	560.000 $	–	–	–
9	9 Worth Venture Partners Fort Lee, New Jersey	397.000 $	–	–	–
10	10 BlackRock New York	271.000 $	–	–	–
11	11 Alyeska Investment Group Chicago, Illinois	207.000 $	–	–	–
12	12 Geode Capital Management Boston, Massachusetts	127.000 $	–	–	–
13	ARTA 13 A.R.T. Advisors New York	116.000 $	–	–	–
14	14 UBS Group Zurich, Switzerland	85.000 $	–	–	–
15	15 Bridgeway Capital Management Houston, Texas	83.000 $	–	–	–
16	16 Virtu Financial New York	78.000 $	–	–	–
17	CL 17 CSS LLC Chicago, Illinois	77.000 $	–	–	–
18	18 Algert Global San Francisco, California	66.000 $	–	–	–
19	19 QS Investors New York	56.000 $	–	–	–
20	20 Boothbay Fund Management New York	53.000 $	–	–	–
21	21 Northern Trust Chicago, Illinois	53.000 $	–	–	–
22	22 Bank of New York Mellon New York	50.000 $	–	–	–
23	23 Atlas Capital Advisors Jackson, Wyoming	43.478 $	–	–	–
24	24 Horizon Kinetics Asset Management New York	33.000 $	–	–	–
25	25 Clifford Swan Investment Counsel Pasadena, California	24.000 $	–	–	–

Aptevo Therapeutics APVO Börsenwert 1,4 Mio. $

Aptevo Therapeutics

APVO

Börsenwert 1,4 Mio. $